Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of WS016 in Patients With Hyperkalemia. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the safety and efficacy of WS016 in patients with hyperkalemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• WS016

Snippet

Sponsor: Waterstone Pharmaceutical (Wuhan) Co., LTD. | Conditions: Hyperkalemia | Phase 2 | Status: UNKNOWN